Coventry Drug Trends Series Continues with an Evaluation of Opioids

In part three of our workers’ compensation drug trends series we’re evaluating opioid trends, which continue to represent a decreasing proportion of overall scripts and costs with favorable trends seen in important markers such as morphine equivalent dose (MED), duration of use, and access to guideline-supported measures including medication-assisted treatment (MAT) and overdose rescue medication (naloxone).
Some highlights from the series include:

• The number of injured workers using opioids has continued to decline for 6 consecutive years
• Opioid script utilization has fallen at least 10% each year for the last 5 years
• First Script® has continuously reduced Morphine equivalent Dose (MED) over the last 9 years

Each part in the series is accompanied by an ongoing deeper dive into various related topics to address the specific trends highlighted in the infographics. To learn more, stay tuned for upcoming blog posts or visit the Sounding Board at: https://blogs.coventrywcs.com/

Previous reports and missed editions of the series can be found on our Drug Trends Page at www.coventrywcs.com/drugtrends.

View Original Press Release


Coventry

Coventry offers workers’ compensation, auto, and disability care-management and cost-containment solutions for employers, insurance carriers, and third-party administrators. With roots in both clinical and network services, Coventry leverages more than 35 years of industry experience, knowledge, and data analytics. Our mission is returning people to work, to play, and to life, and our care-management and cost-containment solutions do just that. Our networks, clinical solutions, specialty programs, and business tools will help you focus on total outcomes.

Ellen Armstrong